Tech Company Financing Transactions

Gro Biosciences Funding Round

Leaps by Bayer, Redmile Group and Digitalis Ventures participated in a $25 million Series A funding round for Gro Biosciences. The funding round was announced on 11/6/2021.

Transaction Overview

Company Name
Gro Biosciences
Announced On
11/6/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors

Leaps by Bayer (Lead Investor) (Jürgen Eckhardt)

Redmile Group (Lead Investor)

Digitalis Ventures (Geoffrey Smith)

Innovation Endeavors

Proceeds Purpose
The capital raised will support development of the GRO platform, scale-up of bioprocess manufacturing, preclinical validation studies and IND-enabling studies for GRObio's pipeline of unique non-standard amino acid (NSAA) protein therapeutics to treat autoimmune and metabolic diseases.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
127 Western Ave.
Boston, MA 02134
USA
Phone
(617) 903-8359
Website
www.grobio.com
Email Address
Not Recorded
Overview
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties.
Profile
Gro Biosciences LinkedIn Company Profile
Social Media
Gro Biosciences Company Twitter Account
Company News
Gro Biosciences News
Facebook
Gro Biosciences on Facebook
YouTube
Gro Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daniel Mandell
  Daniel Mandell LinkedIn Profile  Daniel Mandell Twitter Account  Daniel Mandell News  Daniel Mandell on Facebook
Chief Scientific Officer
Christopher Gregg
  Christopher Gregg LinkedIn Profile  Christopher Gregg Twitter Account  Christopher Gregg News  Christopher Gregg on Facebook
Co-Founder
George Church
  George Church LinkedIn Profile  George Church Twitter Account  George Church News  George Church on Facebook
Co-Founder
Andrew Ellington
  Andrew Ellington LinkedIn Profile  Andrew Ellington Twitter Account  Andrew Ellington News  Andrew Ellington on Facebook
Co-Founder
Marc Lajoie
  Marc Lajoie LinkedIn Profile  Marc Lajoie Twitter Account  Marc Lajoie News  Marc Lajoie on Facebook
Co-Founder
Ross Thyer
  Ross Thyer LinkedIn Profile  Ross Thyer Twitter Account  Ross Thyer News  Ross Thyer on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/6/2021: Kitman Labs venture capital transaction
Next: 11/6/2021: Parthenon Therapeutics venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.